Ibutamoren

Cat. No.: OB0225WX-2237

Appearance: Solid

Purity: ≥97%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Ibutamoren is an orally active growth hormone secretagogue that functions by mimicking the GH-stimulating mechanism of the endogenous ligand ghrelin.

Synonym: MK 677; L 163191; L-163191; L163191; MK677; MK-677; 159634-47-6; 2-amino-2-methyl-N-[(2R)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propanamide; L 163191; (R)-2-amino-N-(3-(benzyloxy)-1-(1-(methylsulfonyl)spiro[indoline-3,4'-piperidin]-1'-yl)-1-oxopropan-2-yl)-2-methylpropanamide; MK-677, (HCl salt); L-163,191; 1-(methanesulfonyl)-1'-(2-methyl-L-alanyl-O-benzyl-D-seryl)-1,2-dihydrospiro[indole-3,4'-piperidine]; Propanamide, 2-amino-N-((1R)-2-(1,2-dihydro-1-(methylsulfonyl)spiro(3H-indole-3,4'-piperidin)-1'-yl)-2-oxo-1-((phenylmethoxy)methyl)ethyl)-2-methyl-; Propanamide, 2-amino-N-(2-(1,2-dihydro-1-(methylsulfonyl)spiro(3H-indole-3,4'-piperidin)-1'-yl)-2-oxo-1-((phenylmethoxy)methyl)ethyl)-2-methyl-, (R)-

CAS No.: 159634-47-6

Compound CID: 178024

Formula: C₂₇H₃₆N₄O₅S

Formula Weight: 528.66

Specification

Relative Density: 1.32 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Ibutamoren is used in endocrine research as an orally active growth hormone secretagogue to investigate the stimulation of the ghrelin receptor and its subsequent impact on increasing insulin-like growth factor 1 (IGF-1) levels.